The microbiome is a rapidly growing market. Understanding the detailed roles and functions of the microbiome is important as it is linked to a multitude of critical areas from human health to environmental sustainability.
(A recent report on “Analytics of the Microbiome” by Arogyam covers all aspects of the microbiome landscape. A free preview of the high value, actionable insights packed microbiome report is available here: https://www.arogyam.biz/download-summary). Arogyam is not a part of Kalorama Information; we are pleased to share this information that may be of interest to our readers.
Publications are a testament to the interest and amount of research activity in the field and are therefore an indicator of market demand. Publication of scientific papers focused on microbiome research has been surging with over 40K publications and a steady growth of 25%+ in the past three years. A Chinese funding agency is the leading body that has been supporting a lot of published research, notable given the current climate with China.
Grants are a close representation of the market opportunity in the academic community. Microbiome research grants continue to increase with $1billion USD being awarded to research in the area. Infectious disease and cancer researchers are the top award recipients. The US and EU have the most funding.
Microbiome Clinical Trials
Investigation of clinical trials is a crucial framework to recognize the influence and impact of the microbiome on human health and diseases. COVID-19 has not dented the number of ongoing clinical trials focused on the microbiome, 2020 is on pace to grow to up to 200 clinical trials. It has an unprecedented influence in the Oncology therapy area. Infectious disease is the top indicator.
Microbiome Startup Activities
Understanding startup activities in not just human health but also across industries such as agriculture, food and beverage is critical to unravel investor enthusiasm. Exponential growth in investment has been seen. 2020 has been a landmark time, over $1.6 billion USD has already been raised even before the year is complete. Investors are betting big in companies in agriculture, food, and infectious disease.
Report abstract can be downloaded here:
And purchased here:
Aruna Rajan is a guest blogger on Kalorama Information, and is Founder & CEO Arogyam LLC.